ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Influenza Virus Rapid Antigen Detection Kits Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-26E16667
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Influenza Virus Rapid Antigen Detection Kits Market Research Report 2024
BUY CHAPTERS

Global Influenza Virus Rapid Antigen Detection Kits Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-26E16667
Report
November 2025
Pages:160
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Abbott
Quidel
Actim
Denka
SG Diagnostics
Guangzhou Wondfo Biotech
Jiangsu Bioperfectus Technologies
Hangzhou Biotest Biotech
Wantai BioPharm
DAAN Gene

Influenza Virus Rapid Antigen Detection Kits Market

The global Influenza Virus Rapid Antigen Detection Kits market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Influenza Virus Rapid Antigen Detection Kits are diagnostic tools used to quickly identify the presence of influenza virus antigens in patient samples, typically respiratory specimens such as nasal swabs or throat swabs. These kits are designed to provide rapid results, often within minutes, aiding in the timely diagnosis and management of influenza infections.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Influenza Virus Rapid Antigen Detection Kits leading manufacturers including Roche, Abbott, Quidel, Actim, Denka, SG Diagnostics, Guangzhou Wondfo Biotech, Jiangsu Bioperfectus Technologies, Hangzhou Biotest Biotech, Wantai BioPharm, etc., dominate supply; the top five capture approximately % of global revenue, with Roche leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Influenza Virus Rapid Antigen Detection Kits market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Influenza Virus Rapid Antigen Detection Kits Market Report

Report Metric Details
Report Name Influenza Virus Rapid Antigen Detection Kits Market
Segment by Type
  • Colloidal Gold Method
  • Immunochromatography
  • Other
Segment by Application
  • Hospital
  • POCT
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Abbott, Quidel, Actim, Denka, SG Diagnostics, Guangzhou Wondfo Biotech, Jiangsu Bioperfectus Technologies, Hangzhou Biotest Biotech, Wantai BioPharm, Daan Gene
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Influenza Virus Rapid Antigen Detection Kits study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Influenza Virus Rapid Antigen Detection Kits Market report?

Ans: The main players in the Influenza Virus Rapid Antigen Detection Kits Market are Roche, Abbott, Quidel, Actim, Denka, SG Diagnostics, Guangzhou Wondfo Biotech, Jiangsu Bioperfectus Technologies, Hangzhou Biotest Biotech, Wantai BioPharm, Daan Gene

What are the Application segmentation covered in the Influenza Virus Rapid Antigen Detection Kits Market report?

Ans: The Applications covered in the Influenza Virus Rapid Antigen Detection Kits Market report are Hospital, POCT, Others

What are the Type segmentation covered in the Influenza Virus Rapid Antigen Detection Kits Market report?

Ans: The Types covered in the Influenza Virus Rapid Antigen Detection Kits Market report are Colloidal Gold Method, Immunochromatography, Other

1 Study Coverage
1.1 Introduction to Influenza Virus Rapid Antigen Detection Kits: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Influenza Virus Rapid Antigen Detection Kits Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Colloidal Gold Method
1.2.3 Immunochromatography
1.2.4 Other
1.3 Market Segmentation by Application
1.3.1 Global Influenza Virus Rapid Antigen Detection Kits Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 POCT
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Influenza Virus Rapid Antigen Detection Kits Revenue Estimates and Forecasts 2020-2031
2.2 Global Influenza Virus Rapid Antigen Detection Kits Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Influenza Virus Rapid Antigen Detection Kits Sales Estimates and Forecasts 2020-2031
2.4 Global Influenza Virus Rapid Antigen Detection Kits Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Influenza Virus Rapid Antigen Detection Kits Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Influenza Virus Rapid Antigen Detection Kits Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Colloidal Gold Method Market Size by Manufacturers
3.5.2 Immunochromatography Market Size by Manufacturers
3.5.3 Other Market Size by Manufacturers
3.6 Global Influenza Virus Rapid Antigen Detection Kits Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Influenza Virus Rapid Antigen Detection Kits Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Influenza Virus Rapid Antigen Detection Kits Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Influenza Virus Rapid Antigen Detection Kits Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Influenza Virus Rapid Antigen Detection Kits Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Influenza Virus Rapid Antigen Detection Kits Sales and Revenue by Type (2020-2031)
6.4 North America Influenza Virus Rapid Antigen Detection Kits Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Influenza Virus Rapid Antigen Detection Kits Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Influenza Virus Rapid Antigen Detection Kits Sales and Revenue by Type (2020-2031)
7.4 Europe Influenza Virus Rapid Antigen Detection Kits Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Influenza Virus Rapid Antigen Detection Kits Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Influenza Virus Rapid Antigen Detection Kits Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Influenza Virus Rapid Antigen Detection Kits Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Influenza Virus Rapid Antigen Detection Kits Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Influenza Virus Rapid Antigen Detection Kits Sales and Revenue by Type (2020-2031)
9.4 Central and South America Influenza Virus Rapid Antigen Detection Kits Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Influenza Virus Rapid Antigen Detection Kits Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Influenza Virus Rapid Antigen Detection Kits Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Influenza Virus Rapid Antigen Detection Kits Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Influenza Virus Rapid Antigen Detection Kits Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Business Overview
11.1.3 Roche Influenza Virus Rapid Antigen Detection Kits Product Models, Descriptions and Specifications
11.1.4 Roche Influenza Virus Rapid Antigen Detection Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Roche Influenza Virus Rapid Antigen Detection Kits Sales by Product in 2024
11.1.6 Roche Influenza Virus Rapid Antigen Detection Kits Sales by Application in 2024
11.1.7 Roche Influenza Virus Rapid Antigen Detection Kits Sales by Geographic Area in 2024
11.1.8 Roche Influenza Virus Rapid Antigen Detection Kits SWOT Analysis
11.1.9 Roche Recent Developments
11.2 Abbott
11.2.1 Abbott Corporation Information
11.2.2 Abbott Business Overview
11.2.3 Abbott Influenza Virus Rapid Antigen Detection Kits Product Models, Descriptions and Specifications
11.2.4 Abbott Influenza Virus Rapid Antigen Detection Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Abbott Influenza Virus Rapid Antigen Detection Kits Sales by Product in 2024
11.2.6 Abbott Influenza Virus Rapid Antigen Detection Kits Sales by Application in 2024
11.2.7 Abbott Influenza Virus Rapid Antigen Detection Kits Sales by Geographic Area in 2024
11.2.8 Abbott Influenza Virus Rapid Antigen Detection Kits SWOT Analysis
11.2.9 Abbott Recent Developments
11.3 Quidel
11.3.1 Quidel Corporation Information
11.3.2 Quidel Business Overview
11.3.3 Quidel Influenza Virus Rapid Antigen Detection Kits Product Models, Descriptions and Specifications
11.3.4 Quidel Influenza Virus Rapid Antigen Detection Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Quidel Influenza Virus Rapid Antigen Detection Kits Sales by Product in 2024
11.3.6 Quidel Influenza Virus Rapid Antigen Detection Kits Sales by Application in 2024
11.3.7 Quidel Influenza Virus Rapid Antigen Detection Kits Sales by Geographic Area in 2024
11.3.8 Quidel Influenza Virus Rapid Antigen Detection Kits SWOT Analysis
11.3.9 Quidel Recent Developments
11.4 Actim
11.4.1 Actim Corporation Information
11.4.2 Actim Business Overview
11.4.3 Actim Influenza Virus Rapid Antigen Detection Kits Product Models, Descriptions and Specifications
11.4.4 Actim Influenza Virus Rapid Antigen Detection Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Actim Influenza Virus Rapid Antigen Detection Kits Sales by Product in 2024
11.4.6 Actim Influenza Virus Rapid Antigen Detection Kits Sales by Application in 2024
11.4.7 Actim Influenza Virus Rapid Antigen Detection Kits Sales by Geographic Area in 2024
11.4.8 Actim Influenza Virus Rapid Antigen Detection Kits SWOT Analysis
11.4.9 Actim Recent Developments
11.5 Denka
11.5.1 Denka Corporation Information
11.5.2 Denka Business Overview
11.5.3 Denka Influenza Virus Rapid Antigen Detection Kits Product Models, Descriptions and Specifications
11.5.4 Denka Influenza Virus Rapid Antigen Detection Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Denka Influenza Virus Rapid Antigen Detection Kits Sales by Product in 2024
11.5.6 Denka Influenza Virus Rapid Antigen Detection Kits Sales by Application in 2024
11.5.7 Denka Influenza Virus Rapid Antigen Detection Kits Sales by Geographic Area in 2024
11.5.8 Denka Influenza Virus Rapid Antigen Detection Kits SWOT Analysis
11.5.9 Denka Recent Developments
11.6 SG Diagnostics
11.6.1 SG Diagnostics Corporation Information
11.6.2 SG Diagnostics Business Overview
11.6.3 SG Diagnostics Influenza Virus Rapid Antigen Detection Kits Product Models, Descriptions and Specifications
11.6.4 SG Diagnostics Influenza Virus Rapid Antigen Detection Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 SG Diagnostics Recent Developments
11.7 Guangzhou Wondfo Biotech
11.7.1 Guangzhou Wondfo Biotech Corporation Information
11.7.2 Guangzhou Wondfo Biotech Business Overview
11.7.3 Guangzhou Wondfo Biotech Influenza Virus Rapid Antigen Detection Kits Product Models, Descriptions and Specifications
11.7.4 Guangzhou Wondfo Biotech Influenza Virus Rapid Antigen Detection Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Guangzhou Wondfo Biotech Recent Developments
11.8 Jiangsu Bioperfectus Technologies
11.8.1 Jiangsu Bioperfectus Technologies Corporation Information
11.8.2 Jiangsu Bioperfectus Technologies Business Overview
11.8.3 Jiangsu Bioperfectus Technologies Influenza Virus Rapid Antigen Detection Kits Product Models, Descriptions and Specifications
11.8.4 Jiangsu Bioperfectus Technologies Influenza Virus Rapid Antigen Detection Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Jiangsu Bioperfectus Technologies Recent Developments
11.9 Hangzhou Biotest Biotech
11.9.1 Hangzhou Biotest Biotech Corporation Information
11.9.2 Hangzhou Biotest Biotech Business Overview
11.9.3 Hangzhou Biotest Biotech Influenza Virus Rapid Antigen Detection Kits Product Models, Descriptions and Specifications
11.9.4 Hangzhou Biotest Biotech Influenza Virus Rapid Antigen Detection Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Hangzhou Biotest Biotech Recent Developments
11.10 Wantai BioPharm
11.10.1 Wantai BioPharm Corporation Information
11.10.2 Wantai BioPharm Business Overview
11.10.3 Wantai BioPharm Influenza Virus Rapid Antigen Detection Kits Product Models, Descriptions and Specifications
11.10.4 Wantai BioPharm Influenza Virus Rapid Antigen Detection Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Wantai BioPharm Recent Developments
11.11 Daan Gene
11.11.1 Daan Gene Corporation Information
11.11.2 Daan Gene Business Overview
11.11.3 Daan Gene Influenza Virus Rapid Antigen Detection Kits Product Models, Descriptions and Specifications
11.11.4 Daan Gene Influenza Virus Rapid Antigen Detection Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Daan Gene Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Influenza Virus Rapid Antigen Detection Kits Industry Chain
12.2 Influenza Virus Rapid Antigen Detection Kits Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Influenza Virus Rapid Antigen Detection Kits Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Influenza Virus Rapid Antigen Detection Kits Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Influenza Virus Rapid Antigen Detection Kits Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Influenza Virus Rapid Antigen Detection Kits Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Roche
Abbott
Quidel
Actim
Denka
SG Diagnostics
Guangzhou Wondfo Biotech
Jiangsu Bioperfectus Technologies
Hangzhou Biotest Biotech
Wantai BioPharm
DAAN Gene
List of Tables
 Table 1. Global Influenza Virus Rapid Antigen Detection Kits Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Influenza Virus Rapid Antigen Detection Kits Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Influenza Virus Rapid Antigen Detection Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Influenza Virus Rapid Antigen Detection Kits Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Influenza Virus Rapid Antigen Detection Kits Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Influenza Virus Rapid Antigen Detection Kits Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Influenza Virus Rapid Antigen Detection Kits Sales by Region (2020-2025) & (K Units)
 Table 8. Global Influenza Virus Rapid Antigen Detection Kits Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Influenza Virus Rapid Antigen Detection Kits Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Influenza Virus Rapid Antigen Detection Kits Sales Share by Manufacturers (2020-2025)
 Table 12. Global Influenza Virus Rapid Antigen Detection Kits Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Influenza Virus Rapid Antigen Detection Kits Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Influenza Virus Rapid Antigen Detection Kits by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Virus Rapid Antigen Detection Kits as of 2024)
 Table 16. Global Influenza Virus Rapid Antigen Detection Kits Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Influenza Virus Rapid Antigen Detection Kits Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Influenza Virus Rapid Antigen Detection Kits Manufacturing Base and Headquarters
 Table 19. Global Influenza Virus Rapid Antigen Detection Kits Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Influenza Virus Rapid Antigen Detection Kits Sales by Type (2020-2025) & (K Units)
 Table 23. Global Influenza Virus Rapid Antigen Detection Kits Sales by Type (2026-2031) & (K Units)
 Table 24. Global Influenza Virus Rapid Antigen Detection Kits Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Influenza Virus Rapid Antigen Detection Kits Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Influenza Virus Rapid Antigen Detection Kits ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Influenza Virus Rapid Antigen Detection Kits Sales by Application (2020-2025) & (K Units)
 Table 29. Global Influenza Virus Rapid Antigen Detection Kits Sales by Application (2026-2031) & (K Units)
 Table 30. Influenza Virus Rapid Antigen Detection Kits High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Influenza Virus Rapid Antigen Detection Kits Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Influenza Virus Rapid Antigen Detection Kits Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Influenza Virus Rapid Antigen Detection Kits ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Influenza Virus Rapid Antigen Detection Kits Growth Accelerators and Market Barriers
 Table 37. North America Influenza Virus Rapid Antigen Detection Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Influenza Virus Rapid Antigen Detection Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Influenza Virus Rapid Antigen Detection Kits Growth Accelerators and Market Barriers
 Table 40. Europe Influenza Virus Rapid Antigen Detection Kits Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Influenza Virus Rapid Antigen Detection Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Influenza Virus Rapid Antigen Detection Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Influenza Virus Rapid Antigen Detection Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Influenza Virus Rapid Antigen Detection Kits Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Influenza Virus Rapid Antigen Detection Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Influenza Virus Rapid Antigen Detection Kits Investment Opportunities and Key Challenges
 Table 47. Central and South America Influenza Virus Rapid Antigen Detection Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Influenza Virus Rapid Antigen Detection Kits Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Influenza Virus Rapid Antigen Detection Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Roche Corporation Information
 Table 51. Roche Description and Major Businesses
 Table 52. Roche Product Models, Descriptions and Specifications
 Table 53. Roche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Roche Sales Value Proportion by Product in 2024
 Table 55. Roche Sales Value Proportion by Application in 2024
 Table 56. Roche Sales Value Proportion by Geographic Area in 2024
 Table 57. Roche Influenza Virus Rapid Antigen Detection Kits SWOT Analysis
 Table 58. Roche Recent Developments
 Table 59. Abbott Corporation Information
 Table 60. Abbott Description and Major Businesses
 Table 61. Abbott Product Models, Descriptions and Specifications
 Table 62. Abbott Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Abbott Sales Value Proportion by Product in 2024
 Table 64. Abbott Sales Value Proportion by Application in 2024
 Table 65. Abbott Sales Value Proportion by Geographic Area in 2024
 Table 66. Abbott Influenza Virus Rapid Antigen Detection Kits SWOT Analysis
 Table 67. Abbott Recent Developments
 Table 68. Quidel Corporation Information
 Table 69. Quidel Description and Major Businesses
 Table 70. Quidel Product Models, Descriptions and Specifications
 Table 71. Quidel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Quidel Sales Value Proportion by Product in 2024
 Table 73. Quidel Sales Value Proportion by Application in 2024
 Table 74. Quidel Sales Value Proportion by Geographic Area in 2024
 Table 75. Quidel Influenza Virus Rapid Antigen Detection Kits SWOT Analysis
 Table 76. Quidel Recent Developments
 Table 77. Actim Corporation Information
 Table 78. Actim Description and Major Businesses
 Table 79. Actim Product Models, Descriptions and Specifications
 Table 80. Actim Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Actim Sales Value Proportion by Product in 2024
 Table 82. Actim Sales Value Proportion by Application in 2024
 Table 83. Actim Sales Value Proportion by Geographic Area in 2024
 Table 84. Actim Influenza Virus Rapid Antigen Detection Kits SWOT Analysis
 Table 85. Actim Recent Developments
 Table 86. Denka Corporation Information
 Table 87. Denka Description and Major Businesses
 Table 88. Denka Product Models, Descriptions and Specifications
 Table 89. Denka Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Denka Sales Value Proportion by Product in 2024
 Table 91. Denka Sales Value Proportion by Application in 2024
 Table 92. Denka Sales Value Proportion by Geographic Area in 2024
 Table 93. Denka Influenza Virus Rapid Antigen Detection Kits SWOT Analysis
 Table 94. Denka Recent Developments
 Table 95. SG Diagnostics Corporation Information
 Table 96. SG Diagnostics Description and Major Businesses
 Table 97. SG Diagnostics Product Models, Descriptions and Specifications
 Table 98. SG Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. SG Diagnostics Recent Developments
 Table 100. Guangzhou Wondfo Biotech Corporation Information
 Table 101. Guangzhou Wondfo Biotech Description and Major Businesses
 Table 102. Guangzhou Wondfo Biotech Product Models, Descriptions and Specifications
 Table 103. Guangzhou Wondfo Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Guangzhou Wondfo Biotech Recent Developments
 Table 105. Jiangsu Bioperfectus Technologies Corporation Information
 Table 106. Jiangsu Bioperfectus Technologies Description and Major Businesses
 Table 107. Jiangsu Bioperfectus Technologies Product Models, Descriptions and Specifications
 Table 108. Jiangsu Bioperfectus Technologies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Jiangsu Bioperfectus Technologies Recent Developments
 Table 110. Hangzhou Biotest Biotech Corporation Information
 Table 111. Hangzhou Biotest Biotech Description and Major Businesses
 Table 112. Hangzhou Biotest Biotech Product Models, Descriptions and Specifications
 Table 113. Hangzhou Biotest Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Hangzhou Biotest Biotech Recent Developments
 Table 115. Wantai BioPharm Corporation Information
 Table 116. Wantai BioPharm Description and Major Businesses
 Table 117. Wantai BioPharm Product Models, Descriptions and Specifications
 Table 118. Wantai BioPharm Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. Wantai BioPharm Recent Developments
 Table 120. Daan Gene Corporation Information
 Table 121. Daan Gene Description and Major Businesses
 Table 122. Daan Gene Product Models, Descriptions and Specifications
 Table 123. Daan Gene Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. Daan Gene Recent Developments
 Table 125. Key Raw Materials Distribution
 Table 126. Raw Materials Key Suppliers
 Table 127. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 128. Milestones in Production Technology Evolution
 Table 129. Distributors List
 Table 130. Market Trends and Market Evolution
 Table 131. Market Drivers and Opportunities
 Table 132. Market Challenges, Risks, and Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources


List of Figures
 Figure 1. Influenza Virus Rapid Antigen Detection Kits Product Picture
 Figure 2. Global Influenza Virus Rapid Antigen Detection Kits Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Colloidal Gold Method Product Picture
 Figure 4. Immunochromatography Product Picture
 Figure 5. Other Product Picture
 Figure 6. Global Influenza Virus Rapid Antigen Detection Kits Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Hospital
 Figure 8. POCT
 Figure 9. Others
 Figure 10. Influenza Virus Rapid Antigen Detection Kits Report Years Considered
 Figure 11. Global Influenza Virus Rapid Antigen Detection Kits Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Influenza Virus Rapid Antigen Detection Kits Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Influenza Virus Rapid Antigen Detection Kits Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Influenza Virus Rapid Antigen Detection Kits Revenue Market Share by Region (2020-2031)
 Figure 15. Global Influenza Virus Rapid Antigen Detection Kits Sales (2020-2031) & (K Units)
 Figure 16. Global Influenza Virus Rapid Antigen Detection Kits Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 17. Global Influenza Virus Rapid Antigen Detection Kits Sales Market Share by Region (2020-2031)
 Figure 18. Top 5 and Top 10 Manufacturers Influenza Virus Rapid Antigen Detection Kits Sales Volume Market Share in 2024
 Figure 19. Global Influenza Virus Rapid Antigen Detection Kits Revenue Market Share Ranking (2024)
 Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 21. Colloidal Gold Method Revenue Market Share by Manufacturer in 2024
 Figure 22. Immunochromatography Revenue Market Share by Manufacturer in 2024
 Figure 23. Other Revenue Market Share by Manufacturer in 2024
 Figure 24. Global Influenza Virus Rapid Antigen Detection Kits Sales Market Share by Type (2020-2031)
 Figure 25. Global Influenza Virus Rapid Antigen Detection Kits Revenue Market Share by Type (2020-2031)
 Figure 26. Global Influenza Virus Rapid Antigen Detection Kits Sales Market Share by Application (2020-2031)
 Figure 27. Global Influenza Virus Rapid Antigen Detection Kits Revenue Market Share by Application (2020-2031)
 Figure 28. North America Influenza Virus Rapid Antigen Detection Kits Sales YoY (2020-2031) & (K Units)
 Figure 29. North America Influenza Virus Rapid Antigen Detection Kits Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. North America Top 5 Manufacturers Influenza Virus Rapid Antigen Detection Kits Sales Revenue (US$ Million) in 2024
 Figure 31. North America Influenza Virus Rapid Antigen Detection Kits Sales Volume (K Units) by Type (2020- 2031)
 Figure 32. North America Influenza Virus Rapid Antigen Detection Kits Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 33. North America Influenza Virus Rapid Antigen Detection Kits Sales Volume (K Units) by Application (2020-2031)
 Figure 34. North America Influenza Virus Rapid Antigen Detection Kits Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 35. US Influenza Virus Rapid Antigen Detection Kits Revenue (2020-2031) & (US$ Million)
 Figure 36. Canada Influenza Virus Rapid Antigen Detection Kits Revenue (2020-2031) & (US$ Million)
 Figure 37. Mexico Influenza Virus Rapid Antigen Detection Kits Revenue (2020-2031) & (US$ Million)
 Figure 38. Europe Influenza Virus Rapid Antigen Detection Kits Sales YoY (2020-2031) & (K Units)
 Figure 39. Europe Influenza Virus Rapid Antigen Detection Kits Revenue YoY (2020-2031) & (US$ Million)
 Figure 40. Europe Top 5 Manufacturers Influenza Virus Rapid Antigen Detection Kits Sales Revenue (US$ Million) in 2024
 Figure 41. Europe Influenza Virus Rapid Antigen Detection Kits Sales Volume (K Units) by Type (2020-2031)
 Figure 42. Europe Influenza Virus Rapid Antigen Detection Kits Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 43. Europe Influenza Virus Rapid Antigen Detection Kits Sales Volume (K Units) by Application (2020-2031)
 Figure 44. Europe Influenza Virus Rapid Antigen Detection Kits Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 45. Germany Influenza Virus Rapid Antigen Detection Kits Revenue (2020-2031) & (US$ Million)
 Figure 46. France Influenza Virus Rapid Antigen Detection Kits Revenue (2020-2031) & (US$ Million)
 Figure 47. U.K. Influenza Virus Rapid Antigen Detection Kits Revenue (2020-2031) & (US$ Million)
 Figure 48. Italy Influenza Virus Rapid Antigen Detection Kits Revenue (2020-2031) & (US$ Million)
 Figure 49. Russia Influenza Virus Rapid Antigen Detection Kits Revenue (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Influenza Virus Rapid Antigen Detection Kits Sales YoY (2020-2031) & (K Units)
 Figure 51. Asia-Pacific Influenza Virus Rapid Antigen Detection Kits Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Asia-Pacific Top 8 Manufacturers Influenza Virus Rapid Antigen Detection Kits Sales Revenue (US$ Million) in 2024
 Figure 53. Asia-Pacific Influenza Virus Rapid Antigen Detection Kits Sales Volume (K Units) by Type (2020- 2031)
 Figure 54. Asia-Pacific Influenza Virus Rapid Antigen Detection Kits Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 55. Asia-Pacific Influenza Virus Rapid Antigen Detection Kits Sales Volume (K Units) by Application (2020-2031)
 Figure 56. Asia-Pacific Influenza Virus Rapid Antigen Detection Kits Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 57. Indonesia Influenza Virus Rapid Antigen Detection Kits Revenue (2020-2031) & (US$ Million)
 Figure 58. Japan Influenza Virus Rapid Antigen Detection Kits Revenue (2020-2031) & (US$ Million)
 Figure 59. South Korea Influenza Virus Rapid Antigen Detection Kits Revenue (2020-2031) & (US$ Million)
 Figure 60. China Taiwan Influenza Virus Rapid Antigen Detection Kits Revenue (2020-2031) & (US$ Million)
 Figure 61. India Influenza Virus Rapid Antigen Detection Kits Revenue (2020-2031) & (US$ Million)
 Figure 62. Central and South America Influenza Virus Rapid Antigen Detection Kits Sales YoY (2020-2031) & (K Units)
 Figure 63. Central and South America Influenza Virus Rapid Antigen Detection Kits Revenue YoY (2020-2031) & (US$ Million)
 Figure 64. Central and South America Top 5 Manufacturers Influenza Virus Rapid Antigen Detection Kits Sales Revenue (US$ Million) in 2024
 Figure 65. Central and South America Influenza Virus Rapid Antigen Detection Kits Sales Volume (K Units) by Type (2021-2031)
 Figure 66. Central and South America Influenza Virus Rapid Antigen Detection Kits Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 67. Central and South America Influenza Virus Rapid Antigen Detection Kits Sales Volume (K Units) by Application (2020-2031)
 Figure 68. Central and South America Influenza Virus Rapid Antigen Detection Kits Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 69. Brazil Influenza Virus Rapid Antigen Detection Kits Revenue (2020-2025) & (US$ Million)
 Figure 70. Argentina Influenza Virus Rapid Antigen Detection Kits Revenue (2020-2025) & (US$ Million)
 Figure 71. Middle East, and Africa Influenza Virus Rapid Antigen Detection Kits Sales YoY (2020-2031) & (K Units)
 Figure 72. Middle East and Africa Influenza Virus Rapid Antigen Detection Kits Revenue YoY (2020-2031) & (US$ Million)
 Figure 73. Middle East and Africa Top 5 Manufacturers Influenza Virus Rapid Antigen Detection Kits Sales Revenue (US$ Million) in 2024
 Figure 74. Middle East and Africa Influenza Virus Rapid Antigen Detection Kits Sales Volume (K Units) by Type (2021-2031)
 Figure 75. South America Influenza Virus Rapid Antigen Detection Kits Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 76. Middle East and Africa Influenza Virus Rapid Antigen Detection Kits Sales Volume (K Units) by Application (2020-2031)
 Figure 77. Middle East and Africa Influenza Virus Rapid Antigen Detection Kits Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 78. GCC Countries Influenza Virus Rapid Antigen Detection Kits Revenue (2020-2025) & (US$ Million)
 Figure 79. Turkey Influenza Virus Rapid Antigen Detection Kits Revenue (2020-2025) & (US$ Million)
 Figure 80. Egypt Influenza Virus Rapid Antigen Detection Kits Revenue (2020-2025) & (US$ Million)
 Figure 81. South Africa Influenza Virus Rapid Antigen Detection Kits Revenue (2020-2025) & (US$ Million)
 Figure 82. Influenza Virus Rapid Antigen Detection Kits Industry Chain Mapping
 Figure 83. Regional Influenza Virus Rapid Antigen Detection Kits Manufacturing Base Distribution (%)
 Figure 84. Global Influenza Virus Rapid Antigen Detection Kits Production Market Share by Region (2020-2031)
 Figure 85. Influenza Virus Rapid Antigen Detection Kits Production Process
 Figure 86. Regional Influenza Virus Rapid Antigen Detection Kits Production Cost Structure
 Figure 87. Channels of Distribution (Direct Vs Distribution)
 Figure 88. Bottom-up and Top-down Approaches for This Report
 Figure 89. Data Triangulation
 Figure 90. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Influenza Virus Rapid Antigen Test Kit Market Research Report 2024
Global Rapid Antigen and Antibody Detection Kits Market Research Report 2025
Global Influenza A B Antigen Test Kit Market Research Report 2024
Global Influenza Virus Immunology Detection Kits Market Research Report 2024
Global Influenza A B Virus Detection Kit Market Research Report 2024
Global Influenza A Antigen Detection Kit Market Research Report 2024
Global Influenza Virus Antibody Test Kits Market Research Report 2024
Global Influenza Virus Nucleic Acid Test Kit Market Research Report 2024
Global Rapid Antigen Test Kit Market Research Report 2024
lnfluenza A B Fast Test Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Influenza A and B Test Kit Market Research Report 2025
Global Influenza A Virus Antigen Detection Kits Market Research Report 2024
Global Avian Influenza Virus Antigen Test Kit Market Research Report 2024
Global Influenza A Virus Detection Reagent Market Research Report 2024
Global Parainfluenza Virus Rapid Test Kits Market Research Report 2024
Rapid Diagnostic Testing for Influenza Market
H1N1 Antigen Detection Reagent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Influenza B Antigen Detection Kits Market Research Report 2024
Global Molecular Influenza Test Market Research Report 2024
Global Monkeypox Rapid Test Kit Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions